| 000 | 00833 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250514015416.0 | ||
| 264 | 0 | _c20011207 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVermylen, J | |
| 245 | 0 | 0 |
_aIncreased mortality with long-term platelet glycoprotein IIb/IIIa antagonists: an explanation? _h[electronic resource] |
| 260 |
_bCirculation _cNov 2001 |
||
| 300 |
_aE109 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aCoronary Artery Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 700 | 1 | _aHoylaerts, M | |
| 700 | 1 | _aArnout, J | |
| 773 | 0 |
_tCirculation _gvol. 104 _gno. 20 _gp. E109 |
|
| 999 |
_c11620816 _d11620816 |
||